JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2004) 180, 357-368       DOI: 10.1677/joe.0.1800357
© 2004 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, S
Right arrow Articles by Fricker, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, S
Right arrow Articles by Fricker, L.
Journal of Endocrinology, Vol 180, Issue 3, 357-368
Copyright © 2004 by Society for Endocrinology


Articles

Obesity and diabetes in transgenic mice expressing proSAAS

S Wei, Y Feng, FY Che, H Pan, N Mzhavia, LA Devi, AA McKinzie, N Levin, WG Richards, and LD Fricker


ProSAAS is a neuroendocrine peptide precursor that potently inhibits prohormone convertase 1 in vitro. To explore the function of proSAAS and its derived peptides, transgenic mice were created which express proSAAS using the beta-actin promoter. The body weight of transgenic mice was normal until approximately 10-12 weeks, and then increased 30-50% over wild-type littermates. Adult transgenic mice had a fat mass approximately twice that of wild-type mice, and fasting blood glucose levels were slightly elevated. In the pituitary, the levels of several fully processed peptides in transgenic mice were not reduced compared with wild-type mice, indicating that the proSAAS transgene did not affect prohormone convertase 1 activity in this tissue. Because the inhibitory potency of proSAAS-derived peptides towards prohormone convertase 1 is much greater in the absence of carboxypeptidase E activity, the proSAAS transgene was also expressed in carboxypeptidase E-deficient Cpe (fat/fat) mice. Although the transgenic mice were born in the expected frequency, 21 of 22 proSAAS transgenic Cpe (fat/fat) mice died between 11 and 26 weeks of age, presumably due to greatly elevated blood glucose. The levels of several pituitary peptides were significantly reduced in the proSAAS transgenic Cpe (fat/fat) mice relative to non-transgenic Cpe (fat/fat) mice, suggesting that the transgene inhibited prohormone convertase 1 in these mice. Taken together, these results are consistent with a role for proSAAS-derived peptides as neuropeptides that influence body weight independently of their function as inhibitors of prohormone convertase 1.


This article has been cited by other articles:


Home page
EndocrinologyHome page
L. D. Fricker
Neuropeptidomics to Study Peptide Processing in Animal Models of Obesity
Endocrinology, September 1, 2007; 148(9): 4185 - 4190.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. S. Gouraud, K. Heesom, S. T. Yao, J. Qiu, J. F. R. Paton, and D. Murphy
Dehydration-Induced Proteome Changes in the Rat Hypothalamo-Neurohypophyseal System
Endocrinology, July 1, 2007; 148(7): 3041 - 3052.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F.-Y. Che, Q. Yuan, E. Kalinina, and L. D. Fricker
Peptidomics of Cpefat/fat Mouse Hypothalamus: EFFECT OF FOOD DEPRIVATION AND EXERCISE ON PEPTIDE LEVELS
J. Biol. Chem., February 11, 2005; 280(6): 4451 - 4461.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Yamazaki, M. Sekiguchi, M. Takamatsu, Y. Tanabe, and S. Nakanishi
Distinct ontogenic and regional expressions of newly identified Cajal-Retzius cell-specific genes during neocorticogenesis
PNAS, October 5, 2004; 101(40): 14509 - 14514.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Endocrinology.